The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
The National Health Commission is China's government department responsible for health and wellness, formulating and implementing national health policies to advance public health.
The Department of Psychological Sciences at UConn is dedicated to research and teaching about the brain, mind, and behavior, offering comprehensive psychology education and specialized training from individual neurons to social interactions that shape society. With over 1000 undergraduate majors and 60+ faculty across five UConn campuses, we boast 50+ externally funded grants.
The School of Psychological Sciences at the University of Newcastle is a leading institution in Australia, offering state-of-the-art facilities, world-class researchers, a vibrant clinic, and award-winning teachers. The school provides opportunities in neuroscience, developmental psychology, abnormal behavior, social psychology, work experience, overseas study, and accredited master's programs for professional psychologist qualifications.